Andere talen genedrive plc

Aandelen

Vertraagde tijd London S.E. Andere beurzen 17:35:07 03-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
4,375 ^GBX	-0,57%		-18,60%	-46,15%

24/04	Genedrive sluit overeenkomst voor klinisch onderzoek in VS voor goedkeuring MT-RNR1 in VS	AN
03/04	FTSE 100 hoger dankzij economische gegevens uit de VS	AN

Genedrive enters clinical trial deal in US for MT-RNR1 US approval	24/04
FTSE 100 up thanks to US economic data	03/04
Genedrive shares surge as UK's NICE backs test for ischaemic stroke	03/04
AIM WINNERS & LOSERS: UK NICE backs Genedrive test; Corero renews deal	03/04
Genedrive's Test Receives Draft Recommendation from UK's NICE	03/04
EARNINGS AND TRADING: 888 advances US exit; Arrow ups reserve estimate	28/03
Genedrive plc Reports Earnings Results for the Half Year Ended December 31, 2023	28/03
Genedrive down as plans equity raise despite GBP800,000 tax credit	15/03
Coro seals sale terms, Powerhouse makes good progress	19/02
Genedrive Seeks Funding for Testing Kit Amid Funding Call Launch of UK-backed Program	19/02
MoneySupermarket credits Insurance for growth in 2023	19/02
Genedrive draws down GBP600,000 on prepayment facility	02/01
Genedrive Secures Financing Under Equity Prepayment Facility	02/01
AIM WINNERS & LOSERS: Genedrive shares jump on orders	20/12
Genedrive shares surge as six countries receive first orders	20/12
Genedrive Jumps on Receipt of Initial Orders for MT-RNR1 Products	20/12
Genedrive plc Announces Initial Overseas Orders of Mt-RNR1 Id Kit	20/12
600 Group disposal and funding talks continue	04/12
Genedrive plc Announces the Genedrive MT-RNR1 Id Kit Is Now in Routine Use in the Trevor Mann Baby Unit	04/12
Genedrive shares fall as annual loss widens but focused on investing	30/11

Geen resultaten voor deze zoekopdracht